**Exhibit
      31.2**


**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. §1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      302 OF THE SARBANES-OXLEY ACT OF 2002**





**Certification**





I,
      James
      Dorst, Chief Financial Officer and Principal Accounting Officer of
      SpectraScience, Inc. certify that:





1.
 
      I have reviewed this report on Form 10-Q of SpectraScience, Inc.





2.
 
      Based on my knowledge, this report does not contain any untrue statement of
      a
      material fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not
      misleading with respect to the period covered by this report;





3.
 
      Based on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the financial
      condition, results of operations and cash flows of SpectraScience, Inc. as
      of,
      and for, the periods presented in this report;





4.
 
      SpectraScience’s other certifying officer and I are responsible for establishing
      and maintaining disclosure controls and procedures (as defined in Exchange
      Act
      Rules 13a-15(e) and 15d-15(e)) and internal control over financial
      reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
      SpectraScience, Inc. and have:





(a)
      Designed such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure that
      material information relating to SpectraScience, Inc., including its
      consolidated subsidiaries, is made known to us by others within those entities,
      particularly during the period in which this report is being
      prepared;


(b)
      Designed such internal control over financial reporting, or caused such internal
      control over financial reporting to be designed under our supervision, to
      provide reasonable assurance regarding the reliability of financial reporting
      and the preparation of financial statements for external purposes in accordance
      with generally accepted accounting principles;


(c)
      Evaluated the effectiveness of SpectraScience’s disclosure controls and
      procedures and presented in this report our conclusions about the effectiveness
      of the disclosure controls and procedures, as of the end of the period covered
      by this report based on such evaluation; and


(d)
      Disclosed in this report any change in SpectraScience’s internal control over
      financial reporting that occurred during the Company’s most recent fiscal
      quarter that has materially affected, or is reasonably likely to materially
      affect, the Company’s internal control over financial reporting;
      and





5.
 
      The Company’s other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the Company’s
      auditors and the audit committee of the Company’s board of directors (or persons
      performing the equivalent functions):





(a)
        All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are reasonably
      likely to adversely affect SpectraScience’s ability to record, process,
      summarize and report financial information; and


(b)
        Any fraud, whether or not material, that involves management or other
      employees who have a significant role in the small business issuer’s internal
      control over financial reporting.





November 13, 2008Signature:
            /s/
                James DorstName:
            James
                DorstChief
                Financial Officer